Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes
<p>Abstract</p> <p>Dysglycaemic disease is one of the most important health issues facing the world in the 21<sup>st </sup>century. Patients with type 2 diabetes and individuals with prediabetes are at risk of developing macrovascular and microvascular complications. Lo...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-08-01
|
| Series: | Cardiovascular Diabetology |
| Online Access: | http://www.cardiab.com/content/6/1/20 |